ABSTRACT Thirty two patients with asbestosis were assessed by means of bronchoalveolar lavage (27 patients) and the half time clearance from lungs to blood (T1/2LB) of an inhaled aerosol of diethylenetriamine pentacetate (DTPA) labelled with technetium 99m (32 patients). T1/2LB was also measured in 20 non-smoking normal individuals and 17 smokers without a history of exposure to asbestos. Thirteen patients (46%) showed an increase in the percentage of neutrophils with or without an increase in the percentage of eosinophils and eight (29%) showed an increased percentage of lymphocytes. The number of neutrophils plus eosinophils expressed as a percentage of the total count was positively correlated with the length of the history of disease (r = 0.53, p < 0.025) and greater percentages were associated with more severe impairment of lung function. Smokers had lower percentages of lymphocytes than non-smokers (p < 0.002) and showed increased proportions of neutrophils and eosinophils more often than non-smokers (p < 0.05). In 18 non-smokers with asbestosis the mean T1/2LB was 33.8 (range 10.0-62.0) minutes, significantly less than 57.2 (30.5-109) minutes in 20 non-smoking normal subjects (p < 0.002). In nonsmokers shorter T1/2 LB correlated with a longer time since first exposure to asbestos (r = -0.65, p < 0.005), longer duration of exposure (r = -0.70, p < 0.001), and a shorter time since last exposure (r = 0.59, p < 0.01). Shorter T1/2LB was also associated with increased inflammatory activity as shown by higher bronchoalveolar lavage cell counts (r = -0.53, p < 0.025) and higher combined percentages of neutrophils, eosinophils, and lymphocytes (r = -0.47, p < 0.05). The
Asbestosis is a progressive disease leading to disability and reduced life expectancy. By the time clinical and radiological features of asbestosis are established drug treatment is usually ineffective. Consequently, the main thrust of research into asbestosis has been directed towards epidemiological studies with the aim of preventing the disease. Although strict precautionary measures are now required for asbestos workers in the United Kingdom, many people continued to have heavy exposure to asbestos until the late 1960s and in some cases the early 1970s and a substantial number of new cases is likely to appear for the next 20 years or more. In countries, notably South Africa, where protective measures during the mining and handling of asbestos are still inadequate, the problem will be even greater.
It may be worth considering formal trials of antiinflammatory treatment since the alternative is continued observation of progressive decline. An active alveolitis has been shown to precede development of fibrosis in various animal experimental models of asbestosis' 2 and it has been suggested that corticosteroid treatment might be effective in patients with active alveolitis.3 There is, however, little information about the alveolitis of asbestosis or about the significance of different cell subpopulations in the air spaces in this disease. Bronchoalveolar lavage is a relatively noninvasive means of sampling the cells associated with 508 the alveolitis of interstitial lung disease. 4 In this study we determined lavage cell profiles and asbestos body counts in asbestosis and related them to the history of asbestos exposure, smoking history, lung function, and progression of disease. We also measured the rate of clearance of an inhaled aerosol of diethylene triamine pentacetate labelled with technetium 99m (99mTc DTPA) from lungs to blood. This is thought to be an index of pulmonary epithelial permeability6 and it has been suggested that it may provide a means of assessing the activity of interstitial lung disease.7 Little is known, however, of the relationship between permeability and cellular processes in the alveoli. We examined the relationship between permeability and alveolar inflammatory activity as reflected by lavage fluid.
Methods

PATIENTS
We studied 31 men and one woman ( Bronchoalveolar lavage was carried out in 27 of the 32 patients (14 non-smokers and 13 smokers). The procedure was carried out through a fibreoptic bronchoscope with three sequential aliquots of 50 ml of sterile normal saline at 37°C and the sample was prepared for total and differential cell counts as previously described.' Manual counts of regular shaped and regular segmented ferroprotein-coated fibres were carried out on samples prepared as follows. A 20 ml aliquot of lavage fluid was centrifuged at 300 g for 10 minutes, the deposit was diluted with 0.5 ml of 0.1M sodium hydroxide and spun at 300 g for 10 minutes in a Shandon Cytospin centrifuge to make slides which were air dried and fixed in methanol. Counts per slide were standardized to 1 ml of fluid.
CLEARANCE OF 99m TcDTPA
The half time clearance in minutes of 99mTc DTPA from lungs to blood (T1/2LB) was measured in all patients. T1/2 LB was also measured in a group of 20 men with a mean age of 54 (range 40-62) years, of whom 12 had never smoked and eight had ceased smoking at least five years previously, and in a group of 17 current smokers (11 men, six women: mean age 42, range 20-62) without known exposure to asbestos. An aerosol was generated from an Acorn jet nebuliser containing 20 mCi 99`Tc DTPA in 4 ml saline. The output was modified by passage through an array of stainless steel ball bearings to remove Gellert, Langford, Winter, Uthayakumar, Sinha, Rudd large particles.6 A cascade impactor showed that 77% of particles were less than 09 9,um and only 4% were greated than 2 ,um 2) .
In a middle aged control population including smokers lavage fluid differential cell counts in our laboratory show up to 11 % lymphocytes, up to 10% neutrophils, and up to 3% eosinophils, with the combined total of neutrophils plus eosinophils not exceeding 10%. 8 We classified cell percentages in this study as increased if they exceeded these values. Eight patients (29%) showed an increased proportion of lymphocytes. In one there was an associated increase in neutrophils and in another an increase in eosinophils, but the other six patients showed the highest increases in lymphocytes (range 22-47% of total cell count) without any increase in neutrophils or eosinophils. Thirteen patients (46%) showed increases in neutrophils; of these, six had associated increases in eosinophils. Three patients (9%) showed small increases in eosinophils alone (4%, 6%, and 6% of the differential count).
We examined the relationships between lavage fluid cell profiles and clinical features. There was no significant difference in cell profiles between patients with and without pleural disease. Percentages of lymphocytes in smokers (mean 5, range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] were lower than in non-smokers (mean 18, range 2-47) (p < 0.002). Smokers had slightly higher percentages of neutrophils plus eosinophils than non-smokers, though these differences were not significant. When their upper limits for cell percentages, however, were compared with those of our control population, they had increased neutrophils and eosinophils, with normal lymphocytes, more often than non-smokers (p < 0.05).
In the group as a whole a longer history of disease was associated with greater percentages of neutrophils plus eosinophils (r = 0.53, p < 0.025). Because neutrophil counts tended to be higher in smokers we also considered the relationship bet- ween length of history of disease and lavage fluid cell profile in smokers and non-smokers separately. Among non-smokers percentages of neutrophils plus eosinophils correlated with a longer history of disease (r = 0.65, p < 0.025), but among smokers the correlation was not significant.
In the group as a whole higher percentages of inflammatory cells other than macrophages were associated with more rapid deterioration in FVC during the previous 12 months (r = 0.45, p < 0.025). No specific relationships between previous deterioration and individual cell types were found. CLEARANCE OF 9tmTc DTPA Figure 3 shows the values for T1/2 LB in the various groups. Mean T1/2LB was 33.8 (10. 
